Hartford Longevity Economy ETF (ARCA: HLGE)

Latest news for Hartford Longevity Economy ETF (ARCA:HLGE)

Technology

Healthcare

Consumer Cyclical

Financial Services

Communication Services

Consumer Defensive

Industrials

Utilities

Real Estate

Other

Basic Materials

The Fund seeks to provide investment results that, before fees and expenses,correspond to the total return performance of the Hartford Longevity Economy Index (LHLGEX) (the Index), whichis designed to generate attractive risk-adjusted returns by investing in companies that comprise industries that reflectcertain themes that are expected to benefit from the growth of the aging population and the substantial buyingpower it represents. The starting longevity economy universe is comprised of industries that the investment adviserbelieves are most likely to benefit from the growth in longevity economy thematic investing. The Fund seeks toinvest in those industries that the investment adviser believes may benefit from providing the goods and services hat reflect the longevity economy themes identified by the investment adviser. These longevity economy themesinclude, but are not limited to, aging in place/home modification, working longer/private education, performancehealth and comfort, wellbeing, maintaining social connections, financial freedom, staying mobile, humanenhancement and leisure and entertainment. These themes may change from time to time as the needs andpreferences of the aging populations develop. The Fund may invest in issuers of any market capitalization althoughthe Fund will generally invest in issuers with large market capitalizations. The Index seeks to address risks andopportunities within theU.S.longevity economy universe by selecting equity securities of companies exhibiting afavorable combination of factor characteristics, including valuation, momentum, and quality. The Index seeks tooutperform a capitalization-weighted universe ofU.S. large capitalization equity securities, as represented by theRussell 3000 Index, over a complete market cycle.

Commvault Systems Inc

Nvidia Corp.

Alphabet Inc., Class A

Ebay Inc.

Qualcomm Inc.

Texas Instruments Inc

Hewlett Packard Enterprise Co.

Apple Inc

H P Inc.

Broadcom Inc. [avgo]

Hartford Longevity Economy ETF

News

Trading Ideas

BEKE

LYFT

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Appaloosa LP 13F Shows Increased Stake In PDD Holdings By 173% From 1,940,000 To 5,301,132 Shares; Increased Stake In JD.com Inc By 69% From 4,310,600 To 7,300,000 Shares;  Increased Stake In Lyft By 98% From 7,961,257 To 15,750,000 Shares; Increased Stake In KE Holdings By 4% From 2,085,000 To 2,175,000 Shares

AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) reported quarterly losses of $(1.10) per share which missed the analyst consensus estimate of $(0.20) by 450 percent. The company reported quarterly sales of $1.100 million which missed the analyst consensus estimate of $24.133 million by 95.44 percent.

Earnings

Earnings Misses

ASTS

AST SpaceMobile Q3 2024 GAAP EPS $(1.10) Misses $(0.20) Estimate, Sales $1.100M Miss $24.133M Estimate

Surf Air Mobility Inc. Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NYSE">SRFM</a>) reported quarterly losses of $(0.94) per share which beat the analyst consensus estimate of $(2.10) by 55.24 percent. The company reported quarterly sales of $28.386 million which beat the analyst consensus estimate of $26.305 million by 7.91 percent. This is a 29.22 percent increase over sales of $21.967 million the same period last year.

Earnings Beats

SRFM

Surf Air Mobility Inc. Common Stock Q3 2024 GAAP EPS $(0.94) Beats $(2.10) Estimate, Sales $28.386M Beat $26.305M Estimate

Emeren Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) lowers FY2024 sales outlook from $150.00 million-160.00 million to $97.00 million-102.00 million.

Guidance

Emeren Group Lowers FY2024 Sales Guidance from $150.00M-$160.00M to $97.00M-$102.00M  VS Est. $151.34M

Precision Optics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POCI#NASDAQ">POCI</a>) reported quarterly losses of $(0.21) per share. This is a 162.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported $4.20 million in sales this quarter. This is a 2.88 percent decrease over sales of $4.32 million the same period last year.

POCI

Precision Optics Corp Q1 EPS $(0.21) Down From $(0.08) YoY, Sales $4.20M Down From $4.32M YoY

Contracts

AXON

Axon To Supply Royal Canadian Mounted Police (RCMP) With Body-Worn Cameras

Ryvyl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVYL#NASDAQ">RVYL</a>) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.27) by 181.48 percent. This is a 26.67 percent decrease over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $12.61 million which missed the analyst consensus estimate of $13.92 million by 9.44 percent. This is a 27.88 percent decrease over sales of $17.48 million the same period last year.

RVYL

Ryvyl Q3 EPS $(0.76) Misses $(0.27) Estimate, Sales $12.61M Miss $13.92M Estimate

Hyliion Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYLN#NYSE">HYLN</a>) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent.

HYLN

Hyliion Holdings Q3 2024 GAAP EPS $(0.06) Beats $(0.07) Estimate

Super League Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLE#NASDAQ">SLE</a>) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.31) by 19.35 percent. This is a 78.45 percent increase over losses of $(1.16) per share from the same period last year. The company reported quarterly sales of $4.43 million which missed the analyst consensus estimate of $6.81 million by 34.91 percent. This is a 38.42 percent decrease over sales of $7.20 million the same period last year.

Super League Enterprise Q3 2024 Adj EPS $(0.25) Beats $(0.31) Estimate, Sales $4.43M Miss $6.81M Estimate

Biotech

Events

General

AMGN

Amgen To Present MITIGATE Phase 3 Study At ACR 2024 Nov. 14-19

WYNN

Appaloosa LP 13F Shows Added Stake In Vistra Corp With 1,270,388 Shares; Added Stake In NRG Energy With 999,820 Shares; Added Stake In Las Vegas Sands Corp With 1,528,323 Shares; Added Stake In Wynn Resorts Ltd With 800,000 Shares

Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) reported quarterly losses of $(0.93) per share. This is a 81.4 percent increase over losses of $(5.00) per share from the same period last year. The company reported $1.87 million in sales this quarter. This is a 89.65 percent increase over sales of $985.52 thousand the same period last year.

SIDU

Sidus Space Q3 EPS $(0.93) Up From $(5.00) YoY, Sales $1.87M Up From $985.52K YoY

Emeren Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) sees Q4 sales of $40.000 million-45.000 million vs $80.26 million estimate.

Emeren Group Sees Q4 Sales $40.000M-45.000M vs $80.26M Est

Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) reported quarterly losses of $(0.23) per share. This is a 84.46 percent increase over losses of $(1.48) per share from the same period last year. The company reported $126.00 thousand in sales this quarter. This is a 55.32 percent decrease over sales of $282.00 thousand the same period last year.

TIVC

Tivic Health Systems Q3 EPS $(0.23) Up From $(1.48) YoY, Sales $126.00K Down From $282.00K YoY

WIIM

DMRC

Digimarc shares are trading lower after the company reported worse-than-expected Q3 financial results.

Genelux (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLX#NASDAQ">GNLX</a>) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent.

GNLX

Genelux Q3 2024 GAAP EPS $(0.19) Beats $(0.20) Estimate

2024 Fourth Quarter and Full Year Outlook
Based on current market conditions, Globant is providing the following estimates for the fourth quarter and the full year of 2024:
<ul>
<li>Fourth quarter 2024 Revenues are estimated to be in the range of $642.0 million to $648.0 million, or 10.6% to 11.6% year-over-year growth.</li>
<li>Fourth quarter 2024 Non-IFRS Adjusted Profit from Operations Margin is estimated to be in the range of 15.0% to 16.0%.</li>
<li>Fourth quarter 2024 Non-IFRS Adjusted Diluted EPS is estimated to be in the range of $1.71 to $1.75 (assuming an average of 44.7 million diluted shares outstanding during the fourth quarter).</li>
<li>Fiscal year 2024 Revenues are estimated to be in the range of $2,415.0 million to $2,421.0 million, implying a 15.2% to 15.5% year-over-year revenue growth.</li>
<li>Fiscal year 2024 Non-IFRS Adjusted Profit from Operations Margin is estimated to be in the range of 15.0% to 15.5%.</li>
<li>Fiscal year 2024 Non-IFRS Adjusted Diluted EPS is estimated to be in the range of $6.37 to $6.43 (assuming an average of 44.5 million diluted shares outstanding during 2024).</li>
</ul>

GLOB

Globant S.A. Sees Q4 Adj. EPS $1.71-$1.75 Vs $1.74 Est.; Revenue $642M-$648M Vs $643M Est.; FY24 EPS $6.37-$6.43 Vs $6.40 Est.; Revenue $2.415B-$2.421B Vs $2.42B Est.

Panbela Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBLA#NASDAQ">PBLA</a>) reported quarterly losses of $(1.48) per share. This is a 97.25 percent increase over losses of $(53.74) per share from the same period last year.

PBLA

Panbela Therapeutics Q3 EPS $(1.48) Up From $(53.74) YoY

SWK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKH#NASDAQ">SWKH</a>) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.52 by 36.54 percent. The company reported $10.418 million in sales this quarter. This is a 16.25 percent increase over sales of $8.962 million the same period last year.

SWKH

SWK Holdings Q3 2024 Adj. EPS $0.33 Misses $0.52 Estimate, Sales $10.418M Up From $8.962M YoY

GameSquare Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAME#NASDAQ">GAME</a>) sees FY2024 sales of $105.000 million-$110.000 million vs $103.00 million estimate.

GAME

GameSquare Holdings Sees FY2024 Sales $105.000M-$110.000M vs $103.00M Est

Falling Rates Could Mean Earnings And Dividend Uncertainty

Fed In Line: Markets Reiterate Strong Buy On Stocks And Bonds

Great Expectations Are Priced For Disappointment

S&P 500 Snapshot: Record-Smashing Week

The Math Is Starting To Work Against Long-Term U.S. Stock Returns

The Post-Election Volatility Surface Realignment

Initiating Upside S&P 500 Index Target Of 7,500

Small Fry, High Fly

Inflection Points: Beyond Regional Conflicts

Markets Rally As The Q3 Earnings Season Enters Its Final Peak Week

ACTV

AFMC

AFSM

AIBU

AMZN

ANEW

ARKK

ARKQ

ARTY

AVUV

BAPR

BBMC

BBSC

BFOR

BKMC

BKSE

BMVP

BOTZ

BOUT

CALF

CBSE

DDIV

DEEP

DEUS

DFAS

DFEN

DGRS

DTCR

DTEC

DVLU

DWAS

EFRA

EQAL

ESML

ETHO

FFSM

FFTY

FIBR

FLQM

FLQS

FNDA

FOVL

FRTY

FSCS

FSMD

FTDS

FTSD

GBIL

GLRY

GOOG

GOOGL

GOVT

GOVZ

GRPM

GSSC

HAIL

HLGE

HOMZ

HSMV

IDGT

IFRA

IGPT

IMCB

IMCG

IMCV

ISCB

ISCG

ISCV

ISMD

IVOG

IVOO

IVOV

JHMM

JHSC

JPME

JPSE

JSMD

JSML

KAPR

KJAN

KJUL

KOMP

LGOV

LMBS

LRNZ

LSAT

MAGS

MDYG

MDYV

MGMT

MIDE

NFRA

NUMG

NUMV

NUSC

OBOR

OMFS

ONEO

ONEV

ONEY

OSCV

Comments

Hartford Longevity Economy ETF

News

Latest news for Hartford Longevity Economy ETF (ARCA:HLGE)

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga